kabutan

Pharma Foods, Ordinary Profit Forecast for Last Fiscal Year Revised Upward by 9%

Mon Sep 8, 2025 3:30 pm JST Revision

2929 Pharma Foods International Co., Ltd. 【J-GAAP】

Guidance Update Report

Pharma Foods International Co., Ltd. <2929> [TSE Prime] announced a performance revision after the market closed on September 8th (15:30). The consolidated ordinary profit forecast for the fiscal year ending July 2025 has been revised upward 8.7%, from the previous forecast of 2.30 billion yen to 2.50 billion yen (compared to 5.24 billion yen in the previous period), and the declining rate is expected to decrease from 56.2% to 52.4%. However, the full-year forecast for consolidated net income has decreased 78.1%, from the previous forecast of 1.60 billion yen to 0.35 billion yen (compared to 3.20 billion yen in the previous period), leading to an increase in the profit decline rate from 50.1% to 89.1%.

Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the February to July period (second half) consolidated ordinary profit has been revised upward 12.1%, from the previous forecast of 1.65 billion yen to 1.85 billion yen (compared to 3.70 billion yen in the same period of the previous year), and the declining rate is expected to decrease from 55.4% to 50.0%.

Kabutan News

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Feb - Jul, 2025 Prev 35,143 1,377 1,655 1,371 47.5 12.50 Mar 12, 2025 J-GAAP
Feb - Jul, 2025 New 35,343 1,677 1,855 121 4.2 12.50 Sep 8, 2025 J-GAAP
Revision Rate +0.6% +21.8% +12.1% -91.2% -91.1%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul, 2025 Prev 65,000 2,000 2,300 1,600 55.4 25 Sep 12, 2024 J-GAAP
Jul, 2025 New 65,200 2,300 2,500 350 12.2 25 Sep 8, 2025 J-GAAP
Revision Rate +0.3% +15.0% +8.7% -78.1% -78.0%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Feb - Jul, 2024 30,495 3,578 3,707 2,437 85.7 15 Sep 12, 2024 J-GAAP
Feb - Jul, 2025 Guidance 35,343 1,677 1,855 121 4.2 12.50 Sep 8, 2025 J-GAAP
YoY +15.9% -53.1% -50.0% -95.0% -95.1%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul, 2023 68,572 3,610 3,540 3,081 106.7 22 Sep 11, 2023 J-GAAP
Jul, 2024 62,147 5,113 5,249 3,205 112.7 25 Sep 12, 2024 J-GAAP
Jul, 2025 Guidance 65,200 2,300 2,500 350 12.2 25 Sep 8, 2025 J-GAAP
YoY +4.9% -55.0% -52.4% -89.1% -89.2%

Related Articles